Opportunistic skin infection in adult-onset immunodeficiency due to anti-interferon-gamma autoantibody: a case report and literature review
Keywords:
anti-interferon-gamma autoantibody, opportunistic infections, rituximabAbstract
SRISANTITHUM B, PONDCHAROEN P. OPPORTUNISTIC SKIN INFECTION IN ADULT-ONSET IMMUNODEFICIENCY DUE TO ANTI-INTERFERON-GAMMA AUTOANTIBODY: A CASE REPORT AND LITERATURE REVIEW. THAI J DERMATOL 2020; 36: 83-89.
DIVISION OF DERMATOLOGY, DEPARTMENT OF INTERNAL MEDICINE, FACULTY OF MEDICINE, THAMMASAT UNIVERSITY, PATHUMTHANI, THAILAND.
An acquired anti-interferon-gamma autoantibody syndrome is well-recognized entity presented in non-HIV and previously healthy patients with susceptibly to severe and recalcitrant intracellular opportunistic infections. We describe a case of HIV-negative, interferon-gamma-autoantibody –positive, Thai male who presented with severe and recalcitrant disseminated Mycobacterium abscessus infection with history of tuberous lymphadenitis, genital herpes simplex and Salmonella group B infection
Keywords: anti-interferon-gamma autoantibody, mycobacterium infection, opportunistic infections
References
Wipasa J, Wongkulab P, Chawansuntati K, Chaiwarit R, Supparatpinyo K. Cellular immune responses in HIV-negative immunodeficiency with anti-interferon-gamma antibodies and opportunistic intracellular microorganisms. PLoS One 2014;9:e110276.
Hase I, Morimoto K, Sakagami T, Ishii Y, van Ingen J. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review. Diagn Microbiol Infect Dis 2017;88:308-15.
Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med 2012;367:725-34.
Kampitak T, Suwanpimolkul G, Browne S, Suankratay C. Anti-interferon-gamma autoantibody and opportunistic infections: case series and review of the literature. Infection 2011;39:65-71.
Angkasekwinai N, Suputtamongkol Y, Phoompoung P, et al. Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-gamma autoantibodies. PLoS One 2019;14:e0215581.
Su SH, Chen YH, Tsai TY, et al. Catheter-related Mycobacterium abscessus bacteremia manifested with skin nodules, pneumonia, and mediastinal lymphadenopathy. Kaohsiung J Med Sci 2013;29:50-4.
Jutivorakool K, Sittiwattanawong P, Kantikosum K, et al. Skin Manifestations in Patients with Adult-onset Immunodeficiency due to Anti-interferon-gamma Autoantibody: A Relationship with Systemic Infections. Acta Derm Venereol 2018;98:742-7.
Tham EH, Huang CH, Soh JY, et al. Neutralizing Anti-Interferon-Gamma Autoantibody Levels May Not Correlate With Clinical Course of Disease. Clin Infect Dis 2016;63:572-3.
Chirasuthat P, Triyangkulsri K, Rutnin S, Chanprapaph K, Vachiramon V. Cutaneous nontuberculous mycobacterial infection in Thailand: A 7-year retrospective review. Medicine (Baltimore) 2020;99:e19355.
Philips RC, Hoyer PE, White SM, et al. Cutaneous nontuberculous mycobacteria infections: A retrospective case series of 78 patients from the Texas Gulf Coast region. J Am Acad Dermatol 2019;81:730-9.
Browne SK, Zaman R, Sampaio EP, et al. Anti-CD20 (rituximab) therapy for anti-IFN-gamma autoantibody-associated nontuberculous mycobacterial infection. Blood 2012;119:3933-9.
Chetchotisakd P, Anunnatsiri S, Nanagara R, Nithichanon A, Lertmemongkolchai G. Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated Mycobacterium abscessus Infection. J Immunol Res 2018;2018:6473629.
Koya T, Tsubata C, Kagamu H, et al. Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex. J Infect Chemother 2009;15:118-22.
Downloads
Published
How to Cite
Issue
Section
License
เนื้อหาและข้อมูลในบทความที่ลงตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นข้อคิดเห็นและความรับผิดชอบของผู้เขียนบทความโดยตรงซึ่งกองบรรณาธิการวารสาร ไม่จำเป็นต้องเห็นด้วย หรือร่วมรับผิดชอบใดๆ
บทความ ข้อมูล เนื้อหา รูปภาพ ฯลฯ ที่ได้รับการตีพิมพ์ในวารสารโรคผิวหนัง ถือเป็นลิขสิทธิ์ของวารสารฯ หากบุคคลหรือหน่วยงานใดต้องการนำทั้งหมดหรือส่วนหนึ่งส่วนใดไปเผยแพร่ต่อหรือเพื่อกระทำการใดๆ จะต้องได้รับอนุญาตเป็นลายลักอักษรจากบรรณาธิการวารสารโรคผิวหนังก่อนเท่านั้น